Yahoo Finance

• Consolidated Revenue: $629.4 million, down 3% year-over-year.

• Adjusted EBITDA: $58.1 million, representing a margin of 9.2%.

• Net Loss Per Share: $0.53, including a noncash goodwill impairment charge of $0.34 per share pretax.

• Free Cash Flow: Net outflow of $16 million, an improvement of $11 million versus the prior year period.

• Cash and Cash Equivalents: Nearly $1.2 billion at quarter end.

• Integrated Care Segment Revenue: $389.5 million, increased 3.3% over the prior year period.

• U.S. Integrated Care Membership: 102.5 million members, up 12% year-over-year.

• U.S. Virtual Visit Volume: Increased by 7% year-over-year.

• Chronic Care Enrollment: 1.15 million, up approximately 3% year-over-year.

• BetterHelp Segment Revenue: $239.9 million, down 11% versus the prior year.

• BetterHelp Adjusted EBITDA: $7.7 million, with a margin of 3.2%.

• Full-Year 2025 Revenue Guidance: $2.047 billion to $2.058 billion.

• Full-Year 2025 Adjusted EBITDA Guidance: $263 million to $304 million.

• Second Quarter Revenue Guidance: $614 million to $633 million.

• Second Quarter Adjusted EBITDA Guidance: $56 million to $70 million.

• Warning! GuruFocus has detected 5 Warning Signs with TDOC.

Release Date: April 30, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• Teladoc Health Inc (NYSE:TDOC) reported revenues and adjusted EBITDA at the higher end of their first-quarter guidance ranges.

• The acquisition of Virtual Mental Health Company UpLift is expected to enhance the BetterHelp segment by providing access to over 100 million covered lives.

• The Integrated Care segment saw a significant milestone with U.S. membership surpassing 100 million, growing by 8.7 million members sequentially.

• International business continues to grow with mid-teens revenue growth on a constant currency basis, showcasing strong performance in both B2B and public health channels.

• Teladoc Health Inc (NYSE:TDOC) was recognized as one of Newsweek's Most Trustworthy Companies in America for 2025, ranking number one in the healthcare and life sciences industry.

Negative Points

• First-quarter consolidated revenue was down 3% year-over-year, and the net loss per share increased compared to the previous year.

• The BetterHelp segment experienced an 11% decline in revenue compared to the prior year, with adjusted EBITDA margin decreasing from 5.7% to 3.2%.

• The company faces potential headwinds from tariffs, which could impact adjusted EBITDA by $5 million to $10 million in 2025.

• There was a slight uptick in churn rates for BetterHelp, indicating potential challenges in retaining users.

• The acquisition of UpLift is expected to lead to an incremental headwind of approximately $10 million to $15 million to 2025 adjusted EBITDA due to additional operational investments.